Hengjin Dong (H Dong)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 40

Top Topics

Methicillin Resistant Staphylococcus Aureus

Acute Lymphoblastic Leukemia

Multiple Myeloma

Top Venues

European journal of ageing

Journal of clinical medicine

JMIR public health and surveillance

Antimicrobial resistance and infection control

This page only lists publications with an associated author ORCID identifier.

Publications

Wenqianzi Yang, Xuemei Zhen, Xueshan Sun, Shikha Upadhyaya Khatiwada, Danhong Yang, Yixi Chen, Peng Dong, Amer Al-Taie, Jason Gordon, Hengjin Dong
Estimating the value of new antibiotic treatment strategies in Zhejiang province, China: cost-effectiveness analysis based on a validated dynamic model. BMJ open 14 (8) (2024)
Meiling Zhang, Bei Zheng, Wenjuan Yang, Hong Jiang, Xueshan Sun, Zixuan Zhao, Gonghua Li, Hengjin Dong
Cost-Effectiveness Analysis of 6 Tyrosine Kinase Inhibitors as First-Line Treatment for ALK-Positive NSCLC in China. Clinical Medicine Insights. Oncology 18 (2024)
Wenqianzi Yang, Xuemei Zhen, Xueshan Sun, Shikha Upadhyaya Khatiwada, Danhong Yang, Yixi Chen, Peng Dong, Amer Al-Taie, Jason Gordon, Hengjin Dong
Estimating the value of new antibiotic treatment strategies in Zhejiang province, China: cost-effectiveness analysis based on a validated dynamic model. BMJ open 14 (8) (2024)
Meiling Zhang, Bei Zheng, Wenjuan Yang, Hong Jiang, Xueshan Sun, Zixuan Zhao, Gonghua Li, Hengjin Dong
Cost-Effectiveness Analysis of 6 Tyrosine Kinase Inhibitors as First-Line Treatment for ALK-Positive NSCLC in China. Clinical Medicine Insights. Oncology 18 (2024)
Weijia Wu, Shuyi Ding, Zhang Mingming, Zhou Yuping, Xueshan Sun, Zixuan Zhao, Yi Yang, Yongxian Hu, Hengjin Dong
Cost effectiveness analysis of CAR-T cell therapy for patients with relapsed/refractory multiple myeloma in China. Journal of medical economics 26 (1) (2023)
Weijia Wu, Shuyi Ding, Zhang Mingming, Zhou Yuping, Xueshan Sun, Zixuan Zhao, Yi Yang, Yongxian Hu, Hengjin Dong
Cost effectiveness analysis of CAR-T cell therapy for patients with relapsed/refractory multiple myeloma in China. Journal of medical economics (2023)
Weijia Wu, Yuping Zhou, Yannan Wang, Syed Afroz Keramat, Namal N Balasooriya, Zixuan Zhao, Yi Yang, Tracy Comans, Hengjin Dong
Value for Money of CAR-T Cell Therapy for Patients with Diffuse Large B-cell Lymphoma in China: Evidence from a Cost-Effectiveness Analysis. Applied health economics and health policy (2023)
Shulin Chen, Yeates Conwell, Jiang Xue, Lydia W Li, Tingjie Zhao, Wan Tang, Hillary Bogner, Hengjin Dong
Effectiveness of integrated care for older adults with depression and hypertension in rural China: A cluster randomized controlled trial. PLoS medicine 19 (10) (2022)
Xiaoqian Hu, Shuyan Gu, Xuemei Zhen, Xueshan Sun, Yuxuan Gu, Hengjin Dong
Trends in activities of daily living disability among Chinese older adults from 1998 to 2018: an age-period-cohort analysis. European journal of ageing 19 (4) (2022)
Jiaer Lin, M Kamrul Islam, Stephen Ross Leeder, Zhaohua Huo, Chi Tim Hung, Eng Kiong Yeoh, James A Gillespie, Hengjin Dong, Jan Erik Askildsen, Dan Liu, Qi Cao, Benjamin Hon Kei Yip, Adriana Castelli
Integrated Care for Multimorbidity Population in Asian Countries: A Scoping Review. International journal of integrated care 22 (1) (2022)
Zixuan Zhao, Lingbin Du, Yuan Yuan Li, Le Wang, Youqing Wang, Yi Yang, Hengjin Dong
Cost-Effectiveness of Lung Cancer Screening Using Low-Dose Computed Tomography Based on Start Age and Interval in China: Modeling Study. JMIR public health and surveillance 8 (7) (2022)
Xiaoqian Hu, Shuyan Gu, Xuemei Zhen, Xueshan Sun, Yuxuan Gu, Hengjin Dong
Trends in activities of daily living disability among Chinese older adults from 1998 to 2018: an age-period-cohort analysis. European journal of ageing 19 (4) (2022)
Shuyan Gu, Xiaoqian Hu, Lizheng Shi, Xuemei Zhen, Xueshan Sun, Minzhuo Huang, Yuxuan Gu, Hengjin Dong
Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis. Journal of clinical medicine 11 (23) (2022)
Xiaoqian Hu, Shuyan Gu, Xuemei Zhen, Xueshan Sun, Yuxuan Gu, Hengjin Dong
Trends in activities of daily living disability among Chinese older adults from 1998 to 2018: an age-period-cohort analysis. European journal of ageing 19 (4) (2022)
Xiaoqian Hu, Shuyan Gu, Xuemei Zhen, Xueshan Sun, Yuxuan Gu, Hengjin Dong
Trends in activities of daily living disability among Chinese older adults from 1998 to 2018: an age-period-cohort analysis. European journal of ageing 19 (4) (2022)
Yuan Yuan Li, Junfang Xu, Yuxuan Gu, Xueshan Sun, Hengjin Dong, Changgui Chen
The Disease and Economic Burdens of Esophageal Cancer in China from 2013 to 2030: Dynamic Cohort Modeling Study. JMIR public health and surveillance 8 (3) (2022)
Xiaoqian Hu, Shuyan Gu, Xuemei Zhen, Xueshan Sun, Yuxuan Gu, Hengjin Dong
Trends in activities of daily living disability among Chinese older adults from 1998 to 2018: an age-period-cohort analysis. European journal of ageing 19 (4) (2022)
Shuyan Gu, Xiaoqian Hu, Lizheng Shi, Xuemei Zhen, Xueshan Sun, Minzhuo Huang, Yuxuan Gu, Hengjin Dong
Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis. Journal of clinical medicine 11 (23) (2022)
Shuyan Gu, Xiaoqian Hu, Xuemei Zhen, Lizheng Shi, Hui Shao, Xueshan Sun, Yuxuan Gu, Minzhuo Huang, Hengjin Dong
Comparison of Glucose-Lowering Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis. Journal of clinical medicine 11 (18) (2022)
Shuyan Gu, Xiaoqian Hu, Lizheng Shi, Xuemei Zhen, Xueshan Sun, Minzhuo Huang, Yuxuan Gu, Hengjin Dong
Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis. Journal of clinical medicine 11 (23) (2022)
Junfang Xu, Yan Luo, Hengjin Dong, Gang Zhao
The Effects of Internet Exposure on Sexual Risk Behavior Among Sexually Experienced Male College Students in China: Cross-sectional Study. JMIR public health and surveillance 8 (5) (2022)
Zixuan Zhao, Lingbin Du, Yuan Yuan Li, Le Wang, Youqing Wang, Yi Yang, Hengjin Dong
Correction: Cost-Effectiveness of Lung Cancer Screening Using Low-Dose Computed Tomography Based on Start Age and Interval in China: Modeling Study. JMIR public health and surveillance 8 (10) (2022)
Xuemei Zhen, Cecilia Stålsby Lundborg, Xueshan Sun, Nina Zhu, Shuyan Gu, Hengjin Dong
Correction to: Economic burden of antibiotic resistance in China: a national level estimate for inpatients. Antimicrobial resistance and infection control 10 (1) (2021)
Zixuan Zhao, Chi Chen, Xueshan Sun, Duo Zhou, Xinwen Huang, Hengjin Dong
Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost-utility analysis. Journal of medical screening (2021)
Xueshan Sun, Xuemei Zhen, Xiaoqian Hu, Yuanyuan Li, ShuYan Gu, Yuxuan Gu, Zixuan Zhao, Wei Yang, Hengjin Dong
Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis. Cost effectiveness and resource allocation : C/E 19 (1) (2021)
Xuemei Zhen, Cecilia Stålsby Lundborg, Xueshan Sun, Nina Zhu, Shuyan Gu, Hengjin Dong
Economic burden of antibiotic resistance in China: a national level estimate for inpatients. Antimicrobial resistance and infection control 10 (1) (2021)
Zixuan Zhao, Lingbin Du, Le Wang, Youqing Wang, Yi Yang, Hengjin Dong
Preferred Lung Cancer Screening Modalities in China: A Discrete Choice Experiment. Cancers 13 (23) (2021)
Shuyan Gu, Xiaoyong Wang, Lizheng Shi, Qiuying Sun, Xiaoqian Hu, Yuxuan Gu, Xueshan Sun, Hengjin Dong
Health-related quality of life of type 2 diabetes patients hospitalized for a diabetes-related complication. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 29 (10) (2020)
Shuyan Gu, Lizheng Shi, Hui Shao, Xiaoyong Wang, Xiaoqian Hu, Yuxuan Gu, Hengjin Dong
Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis. BMC medicine 18 (1) (2020)
Yuanyuan Li, Lingbin Du, Youqing Wang, Yuxuan Gu, Xuemei Zhen, Xiaoqian Hu, Xueshan Sun, Hengjin Dong
Modeling the Cost-effectiveness of Esophageal Cancer Screening in China. Cost effectiveness and resource allocation : C/E 18 (2020)
Xuemei Zhen, Cecilia Stålsby Lundborg, Meiling Zhang, Xueshan Sun, Yuanyuan Li, Xiaoqian Hu, Shuyan Gu, Yuxuan Gu, Jingming Wei, Hengjin Dong
Clinical and economic impact of methicillin-resistant Staphylococcus aureus: a multicentre study in China. Scientific reports 10 (1) (2020)
Minzhuo Huang, Hao Zhang, Yuxuan Gu, Jingming Wei, Shuyan Gu, Xuemei Zhen, Xiaoqian Hu, Xueshan Sun, Hengjin Dong
Outpatient health-seeking behavior of residents in Zhejiang and Qinghai Province, China. BMC public health 19 (1) (2019)
Xiaoqian Hu, Xueshan Sun, Yuanyuan Li, Yuxuan Gu, Minzhuo Huang, Jingming Wei, Xuemei Zhen, Shuyan Gu, Hengjin Dong
Potential gains in health-adjusted life expectancy from reducing four main non-communicable diseases among Chinese elderly. BMC geriatrics 19 (1) (2019)
Xiaoqian Hu, Hao Zhang, Xueshan Sun, Yuxuan Gu, Xuemei Zhen, Shuyan Gu, Yuanyuan Li, Minzhuo Huang, Jingming Wei, Hengjin Dong
Older adults' choices of first-contact care and related factors in Zhejiang and Qinghai Province, China. Geriatrics & gerontology international 19 (9) (2019)
Xuemei Zhen, Cecilia Stålsby Lundborg, Xueshan Sun, Xiaoqian Hu, Hengjin Dong
Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrobial resistance and infection control 8 (2019)
Xuemei Zhen, Hao Zhang, Xiaoqian Hu, Shuyan Gu, Yuanyuan Li, Yuxuan Gu, Minzhuo Huang, Xueshan Sun, Jingming Wei, Hengjin Dong
A comparative study of catastrophic health expenditure in Zhejiang and Qinghai province, China. BMC health services research 18 (1) (2018)
Xuemei Zhen, Yuanyuan Li, Yixi Chen, Peng Dong, Stephanie Liu, Hengjin Dong
Effect of multiple drug resistance on total medical costs among patients with intra-abdominal infections in China. PloS one 13 (3) (2018)
Xiaoqian Hu, Yuhang Zeng, Xuemei Zhen, Hao Zhang, Yuanyuan Li, Shuyan Gu, Hengjin Dong
Cognitive and physical function of people older than 80 years in China from 1998 to 2014. The Journal of international medical research 46 (7) (2018)
X Zhen, Y Chen, X Hu, P Dong, S Gu, Y Y Sheng, Hengjin Dong
The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province, China. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 36 (10) (2017)
Shuyan Gu, Xiaoyong Wang, Qing Qiao, Weiguo Gao, Jian Wang, Hengjin Dong
Cost-effectiveness of exenatide twice daily vs insulin glargine as add-on therapy to oral antidiabetic agents in patients with type 2 diabetes in China. Diabetes, obesity & metabolism 19 (12) (2017)